Company news
Voyageur Pharmaceuticals Ltd news in 2022
Voyageur Pharmaceuticals Ltd's news releases, calls and decks from 2022, newest first.
Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement
December 23, 2022
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing
December 8, 2022
Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation
December 2, 2022
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)
November 28, 2022
Voyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for Customers
October 31, 2022
Voyageur Pharmaceuticals Ltd. Signs an MOU for the Development of Carbon Fullerene Contrast Agents for Medical Imaging Applications and Related Carbon Capture Technology
October 24, 2022
Voyageur Pharmaceuticals Ltd. Submits Notice of Work to Extract 2,000 Tonnes of Barium Sulfate from Frances Creek Project
September 22, 2022
Voyageur Pharmaceuticals Ltd. Announces Resignation of CFO and Appointment of Interim CFO and Shares for Debt Transaction
August 15, 2022
Voyageur Pharmaceuticals Ltd. Announces Closing of Over Subscribed $1Million Private Placement and Issuance of Shares for Debt
June 16, 2022
Voyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private Placement
May 31, 2022
Voyageur Pharmaceuticals Ltd. Announces Proposed Private Placement
May 26, 2022
Voyageur Pharmaceuticals Completes Milestone with the FDA and Continues to Move Towards Commercialization on Three Fronts
May 18, 2022
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt
May 10, 2022
Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report
February 24, 2022
Voyageur Pharmaceuticals Announces Publication of the Jubilee Mountain NI 43-101 Report & Staking of Falcon Claims- Copper Polymetallic Assets
February 16, 2022
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC - Video Available on Investmentpitch.com
January 13, 2022
Voyageur Pharmaceuticals Announces IRR of 137% and NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project
January 11, 2022